CSIMarket



Worst Performing Stocks In Healthcare Sector During The Last 5 Days



 1 Day   Week  Current Month of June  30 Days 
Current Quarter Q2 of 2024  90 Days    Ytd    12 Months 
 

Shares improved by 0.09% on average, in Healthcare Sector during the last 5 days.

Here are the Worst performing stocks in Healthcare Sector.




KEQU

$36.31

$-4.7550 -11.58%
Last 5 Days


KEQU

$36.31

$-4.7550 -11.58%



Kewaunee Scientific Corporation

Kewaunee Scientific Corporation stock went down -11.58% during the last 5 days.


Kewaunee Scientific Corp operates as a global provider of laboratory furniture, fume hoods, and related equipment. Their business model revolves around designing, manufacturing, and installing these products for various industries including pharmaceutical, chemical, and healthcare. They aim to provide customized laboratory solutions while focusing on quality, safety, and compliance with industry standards.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 107.659 mill. $ 198.397 mill. $ 8.972 mill. 3 mill. 12.28 Y/Y -24.32 %
Market Cap. Revenues TTM Net Income TTM

$ 107.659 mill.


$ 198.397 mill.


$ 8.972 mill.

Employees Shares Outstanding P/E

1,357


3 mill.


12.28

Revenue Growth Income Growth

MRQ Y/Y -24.32 %


MRQ Y/Y 130.69 %



QDEL

$35.61

$-4.3600 -10.91%
Last 5 Days


QDEL

$35.61

$-4.3600 -10.91%



Quidelortho Corp

Quidelortho Corp shares dropped -10.91% during the last 5 days.


Quidelortho Corp operates on a business model that focuses on manufacturing and selling orthodontic products. They leverage their expertise in the orthodontic industry to design and create quality products that cater to the needs of orthodontists and patients. Their revenue is generated through the sales of these products to orthodontic practices and distribution through strategic partnerships.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2,382.309 mill. $ 2,966.200 mill. $ -1,723.100 mill. 67 mill. - Y/Y -17.95 %
Market Cap. Revenues TTM Net Income TTM

$ 2,382.309 mill.


$ 2,966.200 mill.


$ -1,723.100 mill.

Employees Shares Outstanding P/E

-


67 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -17.95 %


MRQ Y/Y - %



GH

$29.94

$-1.9000 -5.97%
Last 5 Days


GH

$29.94

$-1.9000 -5.97%



Guardant Health Inc

Guardant Health Inc stock dropped -5.97% during the last 5 days.


Guardant Health Inc*s business model revolves around providing advanced genomic testing services for cancer patients. It specializes in developing liquid biopsy tests that analyze circulating tumor DNA (ctDNA) in the blood. These tests help in early cancer detection, treatment selection, and monitoring of cancer progression. Guardant Health Inc collaborates with healthcare providers, pharmaceutical companies, and researchers to provide these innovative tests and contribute to the advancement of precision medicine in oncology.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 3,644.057 mill. $ 603.725 mill. $ -460.901 mill. 122 mill. - Y/Y 30.90 %
Market Cap. Revenues TTM Net Income TTM

$ 3,644.057 mill.


$ 603.725 mill.


$ -460.901 mill.

Employees Shares Outstanding P/E

1,100


122 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 30.90 %


MRQ Y/Y - %



XRAY

$25.66

$-1.3900 -5.14%
Last 5 Days


XRAY

$25.66

$-1.3900 -5.14%



Dentsply Sirona Inc

Dentsply Sirona Inc shares dropped -5.14% during the last 5 days.


Dentsply Sirona Inc is a leading dental solutions provider, offering a comprehensive portfolio of dental products and technologies. Their business model focuses on manufacturing and distributing dental equipment, consumables, and digital dentistry solutions to dental professionals worldwide. By combining innovation, research, and customer-centricity, they strive to empower dental professionals to deliver the best possible patient care.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 5,350.110 mill. $ 3,906.000 mill. $ -187.000 mill. 209 mill. - Y/Y -3.05 %
Market Cap. Revenues TTM Net Income TTM

$ 5,350.110 mill.


$ 3,906.000 mill.


$ -187.000 mill.

Employees Shares Outstanding P/E

15,000


209 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -3.05 %


MRQ Y/Y - %



RVTY

$107.29

$-5.2600 -4.67%
Last 5 Days


RVTY

$107.29

$-5.2600 -4.67%



Revvity Inc

Revvity Inc shares dropped -4.67% during the last 5 days.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 13,254.392 mill. $ 2,170.922 mill. $ 539.895 mill. 124 mill. 24.54 Y/Y -8.69 %
Market Cap. Revenues TTM Net Income TTM

$ 13,254.392 mill.


$ 2,170.922 mill.


$ 539.895 mill.

Employees Shares Outstanding P/E

-


124 mill.


24.54

Revenue Growth Income Growth

MRQ Y/Y -8.69 %


MRQ Y/Y -69.52 %



TFX

$202.09

$-9.0100 -4.27%
Last 5 Days


TFX

$202.09

$-9.0100 -4.27%



Teleflex Incorporated

Teleflex Incorporated shares dropped -4.27% during the last 5 days.


Teleflex Incorporated operates with a diversified business model focused on the design, development, manufacturing, and distribution of specialty medical devices. The company offers a wide range of products and solutions across multiple medical fields, including critical care, surgical, and respiratory care. Teleflex*s business model centers around providing innovative, high-quality medical technologies to healthcare professionals globally, aiming to improve patient outcomes and enhance procedural efficiency.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 9,577.853 mill. $ 3,000.133 mill. $ 294.869 mill. 47 mill. 32.45 Y/Y 3.69 %
Market Cap. Revenues TTM Net Income TTM

$ 9,577.853 mill.


$ 3,000.133 mill.


$ 294.869 mill.

Employees Shares Outstanding P/E

14,000


47 mill.


32.45

Revenue Growth Income Growth

MRQ Y/Y 3.69 %


MRQ Y/Y -80.08 %



BMY

$40.81

$-1.6000 -3.77%
Last 5 Days


BMY

$40.81

$-1.6000 -3.77%



Bristol myers Squibb Company

Bristol Myers Squibb Company stock dropped -3.77% during the last 5 days.


Bristol Myers Squibb Company is a pharmaceutical firm that operates on a research and development-driven business model, focused on discovering, developing, and delivering innovative medicines to treat various diseases. The company collaborates with academic institutions, government organizations, and other pharmaceutical companies to advance their portfolio of therapeutics and improve patient outcomes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 82,527.659 mill. $ 45,534.000 mill. $ -6,135.000 mill. 2,022 mill. - Y/Y 4.66 %
Market Cap. Revenues TTM Net Income TTM

$ 82,527.659 mill.


$ 45,534.000 mill.


$ -6,135.000 mill.

Employees Shares Outstanding P/E

32,200


2,022 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 4.66 %


MRQ Y/Y - %



BIIB

$223.65

$-6.9800 -3.03%
Last 5 Days


BIIB

$223.65

$-6.9800 -3.03%



Biogen Inc

Biogen Inc shares declined -3.03% during the last 5 days.


Biogen Inc*s business model revolves around researching, developing, and commercializing therapies for neurological and neurodegenerative diseases.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 32,630.535 mill. $ 9,663.100 mill. $ 1,167.300 mill. 146 mill. 27.96 Y/Y -7.00 %
Market Cap. Revenues TTM Net Income TTM

$ 32,630.535 mill.


$ 9,663.100 mill.


$ 1,167.300 mill.

Employees Shares Outstanding P/E

9,610


146 mill.


27.96

Revenue Growth Income Growth

MRQ Y/Y -7.00 %


MRQ Y/Y 1.50 %



MDT

$79.75

$-2.4800 -3.02%
Last 5 Days


MDT

$79.75

$-2.4800 -3.02%



Medtronic Plc

Medtronic Plc shares went down -3.02% during the last 5 days.


Medtronic Plc is a global medical technology company that operates primarily through four business segments: Cardiac and Vascular Group, Minimally Invasive Therapies Group, Restorative Therapies Group, and Diabetes Group. Their business model revolves around designing, manufacturing, and distributing medical devices and therapies for the treatment of a wide range of medical conditions, including cardiovascular diseases, neurological disorders, and diabetes. Medtronic Plc also focuses on collaborating with healthcare providers to improve patient outcomes and reduce healthcare costs through innovative solutions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 106,203.075 mill. $ 32,319.000 mill. $ 4,234.000 mill. 1,332 mill. 25.34 Y/Y 4.68 %
Market Cap. Revenues TTM Net Income TTM

$ 106,203.075 mill.


$ 32,319.000 mill.


$ 4,234.000 mill.

Employees Shares Outstanding P/E

95,000


1,332 mill.


25.34

Revenue Growth Income Growth

MRQ Y/Y 4.68 %


MRQ Y/Y 8.79 %



OGN

$20.35

$-0.4900 -2.35%
Last 5 Days


OGN

$20.35

$-0.4900 -2.35%



Organon and Co

Organon And Co shares dropped -2.35% during the last 5 days.


Organon and Co*s business model revolves around developing and manufacturing pharmaceutical products.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 5,257.667 mill. $ 6,347.000 mill. $ 1,047.000 mill. 258 mill. 4.99 Y/Y 5.46 %
Market Cap. Revenues TTM Net Income TTM

$ 5,257.667 mill.


$ 6,347.000 mill.


$ 1,047.000 mill.

Employees Shares Outstanding P/E

9,300


258 mill.


4.99

Revenue Growth Income Growth

MRQ Y/Y 5.46 %


MRQ Y/Y 13.56 %



THC

$137.51

$-3.2400 -2.30%
Last 5 Days


THC

$137.51

$-3.2400 -2.30%



Tenet Healthcare Corp

Tenet Healthcare Corp stock dropped -2.30% during the last 5 days.


Tenet Healthcare Corp operates as a healthcare services company that primarily focuses on managing and providing healthcare facilities, including hospitals, outpatient centers, and physician practices. Their business model revolves around delivering high-quality patient care, optimizing operational efficiency, and maintaining strong physician relationships. They aim to provide comprehensive healthcare services to diverse communities, utilizing advanced medical technology and a multispecialty approach to address the healthcare needs of individuals.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 13,833.231 mill. $ 20,895.000 mill. $ 3,349.000 mill. 101 mill. 5.31 Y/Y 6.91 %
Market Cap. Revenues TTM Net Income TTM

$ 13,833.231 mill.


$ 20,895.000 mill.


$ 3,349.000 mill.

Employees Shares Outstanding P/E

108,000


101 mill.


5.31

Revenue Growth Income Growth

MRQ Y/Y 6.91 %


MRQ Y/Y 688.51 %



WAT

$294.4

$-6.5600 -2.18%
Last 5 Days


WAT

$294.4

$-6.5600 -2.18%



Waters Corp

Waters Corp shares declined -2.18% during the last 5 days.


Waters Corp is a global scientific company that primarily operates in the field of analytical instrument systems. They specialize in the development, manufacturing, and sale of high-performance liquid chromatography (HPLC), mass spectrometry (MS), and thermal analysis systems for laboratory use. By providing efficient and advanced solutions to customers, Waters Corp aims to assist various industries in their research, development, and quality control processes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 22,181.568 mill. $ - mill. $ 593.794 mill. 75 mill. 38.38 Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 22,181.568 mill.


$ - mill.


$ 593.794 mill.

Employees Shares Outstanding P/E

7,800


75 mill.


38.38

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



IQV

$212.83

$-4.6300 -2.13%
Last 5 Days


IQV

$212.83

$-4.6300 -2.13%



Iqvia Holdings Inc

Iqvia Holdings Inc stock declined -2.13% during the last 5 days.


IQVIA Holdings Inc is a multinational company that operates in the healthcare industry. Its business model revolves around providing advanced analytics, technology solutions, and clinical research services to help clients make informed decisions, optimize their operations, and accelerate drug development. By leveraging its vast data resources and expertise, IQVIA aims to support healthcare professionals in improving patient outcomes and driving innovation in the industry.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 39,224.569 mill. $ 15,069.000 mill. $ 1,357.000 mill. 184 mill. 28.93 Y/Y 2.33 %
Market Cap. Revenues TTM Net Income TTM

$ 39,224.569 mill.


$ 15,069.000 mill.


$ 1,357.000 mill.

Employees Shares Outstanding P/E

79,000


184 mill.


28.93

Revenue Growth Income Growth

MRQ Y/Y 2.33 %


MRQ Y/Y -0.35 %



PODD

$196.4

$-4.2700 -2.13%
Last 5 Days


PODD

$196.4

$-4.2700 -2.13%



Insulet Corporation

Insulet Corporation shares dropped -2.13% during the last 5 days.


Insulet Corporation operates under a business model where they design, develop, and market innovative tubeless insulin delivery systems for people with diabetes. Their main product, the Omnipod System, is a wearable device that provides continuous insulin delivery without the need for traditional insulin pumps and tubing. This unique business model focuses on improving the quality of life for individuals with diabetes by offering a convenient and user-friendly insulin management solution.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 14,482.732 mill. $ 1,780.700 mill. $ 234.000 mill. 74 mill. 63.83 Y/Y 23.35 %
Market Cap. Revenues TTM Net Income TTM

$ 14,482.732 mill.


$ 1,780.700 mill.


$ 234.000 mill.

Employees Shares Outstanding P/E

3,500


74 mill.


63.83

Revenue Growth Income Growth

MRQ Y/Y 23.35 %


MRQ Y/Y 116.39 %



CRL

$209.8

$-4.0400 -1.89%
Last 5 Days


CRL

$209.8

$-4.0400 -1.89%



Charles River Laboratories International inc

Charles River Laboratories International Inc stock went down -1.89% during the last 5 days.


Charles River Laboratories International Inc is a contract research organization (CRO) that provides essential services and support to the pharmaceutical, biotech, and medical device industries. They offer a wide range of research models, drug discovery and development services, safety assessments, and laboratory animal medicine to assist in the preclinical and clinical stages of drug development.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 10,876.452 mill. $ 4,111.596 mill. $ 450.898 mill. 52 mill. 24.67 Y/Y -1.73 %
Market Cap. Revenues TTM Net Income TTM

$ 10,876.452 mill.


$ 4,111.596 mill.


$ 450.898 mill.

Employees Shares Outstanding P/E

20,000


52 mill.


24.67

Revenue Growth Income Growth

MRQ Y/Y -1.73 %


MRQ Y/Y -28.35 %



GILD

$63.15

$-1.1900 -1.85%
Last 5 Days


GILD

$63.15

$-1.1900 -1.85%



Gilead Sciences Inc

Gilead Sciences Inc stock dropped -1.85% during the last 5 days.


Gilead Sciences Inc*s business model revolves around researching, developing, and commercializing innovative medicines in various therapeutic areas, with a primary focus on antiviral drugs. They aim to address unmet medical needs and improve the lives of patients worldwide.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 78,748.050 mill. $ 27,450.000 mill. $ 458.000 mill. 1,247 mill. 174.36 Y/Y 5.26 %
Market Cap. Revenues TTM Net Income TTM

$ 78,748.050 mill.


$ 27,450.000 mill.


$ 458.000 mill.

Employees Shares Outstanding P/E

14,400


1,247 mill.


174.36

Revenue Growth Income Growth

MRQ Y/Y 5.26 %


MRQ Y/Y - %



MRK

$127.99

$-2.2100 -1.70%
Last 5 Days


MRK

$127.99

$-2.2100 -1.70%



Merck and Co Inc

Merck And Co Inc shares declined -1.70% during the last 5 days.


Merck and Co Inc operates primarily as a research-intensive pharmaceutical company, engaging in the development, manufacturing, and marketing of prescription drugs and vaccines worldwide. The company focuses on discovering innovative solutions to address unmet medical needs across various therapeutic areas, collaborating with academic institutions and conducting clinical trials to evaluate the efficacy and safety of their products. Merck and Co Inc also holds a strong commitment to the well-being of patients and aims to contribute to global healthcare by delivering high-quality, affordable medications.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 325,929.615 mill. $ 61,403.000 mill. $ 2,319.000 mill. 2,547 mill. 135.69 Y/Y 8.89 %
Market Cap. Revenues TTM Net Income TTM

$ 325,929.615 mill.


$ 61,403.000 mill.


$ 2,319.000 mill.

Employees Shares Outstanding P/E

68,000


2,547 mill.


135.69

Revenue Growth Income Growth

MRQ Y/Y 8.89 %


MRQ Y/Y 68.74 %



CTLT

$55.07

$-0.8800 -1.57%
Last 5 Days


CTLT

$55.07

$-0.8800 -1.57%



Catalent Inc

Catalent Inc stock went down -1.57% during the last 5 days.


Catalent Inc*s business model is based on providing advanced delivery technologies and development solutions for pharmaceutical, biotechnology, and consumer health companies. They offer a range of services including drug development, manufacturing, packaging, and supply chain capabilities. Their focus is on helping their clients bring innovative and life-saving products to market efficiently and effectively.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 9,932.268 mill. $ 4,135.000 mill. $ -1,176.000 mill. 180 mill. - Y/Y 3.57 %
Market Cap. Revenues TTM Net Income TTM

$ 9,932.268 mill.


$ 4,135.000 mill.


$ -1,176.000 mill.

Employees Shares Outstanding P/E

19,000


180 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 3.57 %


MRQ Y/Y - %



BSX

$76.31

$-1.1000 -1.42%
Last 5 Days


BSX

$76.31

$-1.1000 -1.42%



Boston Scientific Corporation

Boston Scientific Corporation stock went down -1.42% during the last 5 days.


Boston Scientific Corporation*s business model revolves around designing, developing, and manufacturing a wide range of medical devices that are used in various medical specialties. The company focuses on creating innovative products that address unmet medical needs and improve patient outcomes. They sell these devices to healthcare professionals and hospitals worldwide, leveraging their strong sales and distribution networks. Additionally, Boston Scientific actively invests in research and development to continuously bring new technologies and solutions to the market.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 113,068.527 mill. $ 14,709.000 mill. $ 1,771.000 mill. 1,482 mill. 66.19 Y/Y 13.81 %
Market Cap. Revenues TTM Net Income TTM

$ 113,068.527 mill.


$ 14,709.000 mill.


$ 1,771.000 mill.

Employees Shares Outstanding P/E

41,000


1,482 mill.


66.19

Revenue Growth Income Growth

MRQ Y/Y 13.81 %


MRQ Y/Y 57.01 %



ARGX

$377.96

$-4.5400 -1.19%
Last 5 Days


ARGX

$377.96

$-4.5400 -1.19%



Argenx se

Argenx Se stock went down -1.19% during the last 5 days.


Argenx is a biopharmaceutical company that utilizes its proprietary antibody discovery platform to develop and commercialize transformative antibody-based therapies for the treatment of severe autoimmune diseases and cancer. Their business model focuses on discovering and developing novel antibodies, partnering with pharmaceutical companies for clinical development, and retaining rights to commercialize the therapies in specific regions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 21,607.691 mill. $ 2,494.910 mill. $ -295.053 mill. 57 mill. - Y/Y 191.46 %
Market Cap. Revenues TTM Net Income TTM

$ 21,607.691 mill.


$ 2,494.910 mill.


$ -295.053 mill.

Employees Shares Outstanding P/E

-


57 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 191.46 %


MRQ Y/Y - %



DGX

$137.3

$-1.5300 -1.10%
Last 5 Days


DGX

$137.3

$-1.5300 -1.10%



Quest Diagnostics Inc

Quest Diagnostics Inc stock went down -1.10% during the last 5 days.


Quest Diagnostics Inc operates as a provider of clinical laboratory and diagnostic information services, serving patients, physicians, hospitals, and pharmaceutical companies. The company generates revenue by offering a range of diagnostic testing services, including laboratory analysis, test development, and specialized diagnostics.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 15,377.600 mill. $ 9,287.000 mill. $ 899.000 mill. 112 mill. 18.52 Y/Y 1.50 %
Market Cap. Revenues TTM Net Income TTM

$ 15,377.600 mill.


$ 9,287.000 mill.


$ 899.000 mill.

Employees Shares Outstanding P/E

49,000


112 mill.


18.52

Revenue Growth Income Growth

MRQ Y/Y 1.50 %


MRQ Y/Y -4.15 %



PFE

$27.41

$-0.2500 -0.90%
Last 5 Days


PFE

$27.41

$-0.2500 -0.90%



Pfizer Inc

Pfizer Inc shares went down -0.90% during the last 5 days.


Pfizer Inc operates as a global pharmaceutical company, focused on discovering, developing, manufacturing, and marketing innovative medicines. Its business model revolves around investing in research and development to create a diverse portfolio of therapies across various therapeutic areas. Leveraging its scale, Pfizer aims to commercialize these products globally and drive growth through strategic alliances and collaborations with other industry players.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 156,154.770 mill. $ 55,093.000 mill. $ -275.000 mill. 5,697 mill. - Y/Y -18.61 %
Market Cap. Revenues TTM Net Income TTM

$ 156,154.770 mill.


$ 55,093.000 mill.


$ -275.000 mill.

Employees Shares Outstanding P/E

79,000


5,697 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -18.61 %


MRQ Y/Y -43.79 %



ZBH

$106.69

$-0.7600 -0.71%
Last 5 Days


ZBH

$106.69

$-0.7600 -0.71%



Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc stock went down -0.71% during the last 5 days.


Zimmer Biomet Holdings Inc operates as a global leader in musculoskeletal healthcare, providing innovative solutions for joint replacement, sports medicine, spine, dental implants, and other surgical products. The company*s business model centers around designing, manufacturing, and marketing these medical devices and equipment to healthcare professionals worldwide, with a focus on improving patient outcomes and advancing the field of musculoskeletal healthcare.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 22,404.900 mill. $ 7,279.300 mill. $ 475.200 mill. 210 mill. 47.23 Y/Y 5.02 %
Market Cap. Revenues TTM Net Income TTM

$ 22,404.900 mill.


$ 7,279.300 mill.


$ 475.200 mill.

Employees Shares Outstanding P/E

19,500


210 mill.


47.23

Revenue Growth Income Growth

MRQ Y/Y 5.02 %


MRQ Y/Y -16.12 %



MMM

$100.77

$-0.4400 -0.43%
Last 5 Days


MMM

$100.77

$-0.4400 -0.43%



3m Company

3m Company stock declined -0.43% during the last 5 days.


3M Company is a diversified technology company that operates through various business segments. It focuses on innovation and develops a wide range of products across industries such as healthcare, transportation, consumer goods, and electronics. Its business model involves creating innovative solutions, leveraging its vast portfolio of patents, and maintaining strong relationships with customers and suppliers.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 56,018.043 mill. $ 32,653.000 mill. $ -7,027.000 mill. 556 mill. - Y/Y -0.35 %
Market Cap. Revenues TTM Net Income TTM

$ 56,018.043 mill.


$ 32,653.000 mill.


$ -7,027.000 mill.

Employees Shares Outstanding P/E

95,000


556 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -0.35 %


MRQ Y/Y -4.89 %



ABT

$103.99

$-0.3900 -0.37%
Last 5 Days


ABT

$103.99

$-0.3900 -0.37%



Abbott Laboratories

Abbott Laboratories shares declined -0.37% during the last 5 days.


Abbott Laboratories operates as a diversified healthcare company with a broad portfolio of products. Their business model is centered around developing and manufacturing various health-related products, including pharmaceuticals, medical devices, nutritional products, and diagnostic technologies. They aim to serve a wide range of healthcare sectors globally by providing innovative solutions that improve the quality of patients* lives.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 181,946.311 mill. $ 40,326.000 mill. $ 5,630.000 mill. 1,750 mill. 32.33 Y/Y 2.23 %
Market Cap. Revenues TTM Net Income TTM

$ 181,946.311 mill.


$ 40,326.000 mill.


$ 5,630.000 mill.

Employees Shares Outstanding P/E

113,000


1,750 mill.


32.33

Revenue Growth Income Growth

MRQ Y/Y 2.23 %


MRQ Y/Y -7.06 %



DVA

$142.21

$-0.4800 -0.34%
Last 5 Days


DVA

$142.21

$-0.4800 -0.34%



Davita Inc

Davita Inc stock declined -0.34% during the last 5 days.


Davita Inc operates a network of dialysis centers worldwide, providing kidney care and related services to patients with chronic kidney disease. The company primarily generates revenue through reimbursements from healthcare payors and government programs for the dialysis treatments it offers.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 12,876.689 mill. $ 12,338.003 mill. $ 1,092.290 mill. 91 mill. 16.18 Y/Y 6.89 %
Market Cap. Revenues TTM Net Income TTM

$ 12,876.689 mill.


$ 12,338.003 mill.


$ 1,092.290 mill.

Employees Shares Outstanding P/E

69,000


91 mill.


16.18

Revenue Growth Income Growth

MRQ Y/Y 6.89 %


MRQ Y/Y 79.28 %



BDX

$233.73

$-0.2600 -0.11%
Last 5 Days


BDX

$233.73

$-0.2600 -0.11%



Becton Dickinson And Company

Becton Dickinson And Company shares went down -0.11% during the last 5 days.


Becton Dickinson and Company is a global medical technology company that manufactures and sells a wide range of medical devices, instruments, and reagents. They operate under a business model centered around delivering innovative healthcare solutions to improve patient outcomes and enhance clinical efficiencies.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 67,844.870 mill. $ 19,716.000 mill. $ 1,332.000 mill. 290 mill. 51.52 Y/Y 4.65 %
Market Cap. Revenues TTM Net Income TTM

$ 67,844.870 mill.


$ 19,716.000 mill.


$ 1,332.000 mill.

Employees Shares Outstanding P/E

77,000


290 mill.


51.52

Revenue Growth Income Growth

MRQ Y/Y 4.65 %


MRQ Y/Y 16.49 %



JNJ

$145.65

$0.2400 0.17%
Last 5 Days


JNJ

$145.65

$0.2400 0.17%



Johnson and Johnson

Johnson And Johnson shares improved 0.17% during the last 5 days.


Johnson & Johnson operates as a multinational healthcare company with a diversified model. They develop, manufacture, and sell a broad range of pharmaceutical, medical devices, and consumer goods. Their business is focused on improving the health and well-being of people worldwide through innovation, research, and strategic acquisitions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 353,944.065 mill. $ 89,659.000 mill. $ 38,476.000 mill. 2,430 mill. 9.59 Y/Y -13.59 %
Market Cap. Revenues TTM Net Income TTM

$ 353,944.065 mill.


$ 89,659.000 mill.


$ 38,476.000 mill.

Employees Shares Outstanding P/E

141,700


2,430 mill.


9.59

Revenue Growth Income Growth

MRQ Y/Y -13.59 %


MRQ Y/Y - %



SYK

$348.67

$2.2600 0.65%
Last 5 Days


SYK

$348.67

$2.2600 0.65%



Stryker Corp

Stryker Corp stock went up 0.65% during the last 5 days.


Stryker Corp*s business model is based on developing and manufacturing a wide range of medical technologies and devices for the healthcare industry.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 134,272.817 mill. $ 20,963.000 mill. $ 3,361.000 mill. 385 mill. 39.88 Y/Y 9.73 %
Market Cap. Revenues TTM Net Income TTM

$ 134,272.817 mill.


$ 20,963.000 mill.


$ 3,361.000 mill.

Employees Shares Outstanding P/E

46,000


385 mill.


39.88

Revenue Growth Income Growth

MRQ Y/Y 9.73 %


MRQ Y/Y 33.11 %



BAX

$33.73

$0.4200 1.26%
Last 5 Days


BAX

$33.73

$0.4200 1.26%



Baxter International Inc

Baxter International Inc stock increased 1.26% during the last 5 days.


Baxter International Inc is a global healthcare company that specializes in providing a wide range of medical products and services. They operate through various business segments including Pharmaceuticals, Medical Products, and Renal Care, offering solutions for hospitals, clinics, and home-based healthcare settings.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 17,202.300 mill. $ 14,756.000 mill. $ 2,657.000 mill. 510 mill. 6.48 Y/Y -1.56 %
Market Cap. Revenues TTM Net Income TTM

$ 17,202.300 mill.


$ 14,756.000 mill.


$ 2,657.000 mill.

Employees Shares Outstanding P/E

60,000


510 mill.


6.48

Revenue Growth Income Growth

MRQ Y/Y -1.56 %


MRQ Y/Y -13.33 %



A

$134.9

$1.7400 1.31%
Last 5 Days


A

$134.9

$1.7400 1.31%



Agilent Technologies inc

Agilent Technologies Inc shares increased 1.31% during the last 5 days.


Agilent Technologies Inc. operates under a business model focused on providing innovative measurement solutions to various industries, including life sciences, diagnostics, and chemical analysis. They generate revenue through the sale of their instruments, software, and consumables, as well as offering services to support these products. Agilent also maintains strong collaborations and partnerships with key players in the industry to further expand their reach and impact.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 39,525.700 mill. $ 6,650.000 mill. $ 1,196.000 mill. 293 mill. 33.05 Y/Y -10.42 %
Market Cap. Revenues TTM Net Income TTM

$ 39,525.700 mill.


$ 6,650.000 mill.


$ 1,196.000 mill.

Employees Shares Outstanding P/E

18,100


293 mill.


33.05

Revenue Growth Income Growth

MRQ Y/Y -10.42 %


MRQ Y/Y -12.50 %



MTD

$1481.07

$21.5600 1.48%
Last 5 Days


MTD

$1481.07

$21.5600 1.48%



Mettler Toledo International Inc

Mettler Toledo International Inc shares increased 1.48% during the last 5 days.


Mettler Toledo International Inc*s business model revolves around manufacturing and selling precision instruments and solutions for weighing, measuring, and analyzing various materials and substances.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 31,907.155 mill. $ 3,785.520 mill. $ 777.861 mill. 22 mill. 41.49 Y/Y -0.30 %
Market Cap. Revenues TTM Net Income TTM

$ 31,907.155 mill.


$ 3,785.520 mill.


$ 777.861 mill.

Employees Shares Outstanding P/E

17,800


22 mill.


41.49

Revenue Growth Income Growth

MRQ Y/Y -0.30 %


MRQ Y/Y -5.79 %



ISRG

$435

$6.9000 1.61%
Last 5 Days


ISRG

$435

$6.9000 1.61%



Intuitive Surgical Inc

Intuitive Surgical Inc shares went up 1.61% during the last 5 days.


Intuitive Surgical Inc*s business model revolves around providing robotic surgical systems, instruments, and accessories to hospitals and healthcare facilities. Their flagship product, the da Vinci Surgical System, enables surgeons to perform minimally invasive surgeries with enhanced precision and control. The company generates revenue through the sale of these systems and associated instruments, as well as through training, services, and maintenance provided to its customers.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 156,817.500 mill. $ 7,317.700 mill. $ 2,003.900 mill. 361 mill. 78.33 Y/Y 11.45 %
Market Cap. Revenues TTM Net Income TTM

$ 156,817.500 mill.


$ 7,317.700 mill.


$ 2,003.900 mill.

Employees Shares Outstanding P/E

9,793


361 mill.


78.33

Revenue Growth Income Growth

MRQ Y/Y 11.45 %


MRQ Y/Y 51.72 %



AMGN

$305.99

$4.9100 1.63%
Last 5 Days


AMGN

$305.99

$4.9100 1.63%



Amgen Inc

Amgen Inc stock increased 1.63% during the last 5 days.


Amgen Inc*s business model is centered around developing, manufacturing, and commercializing innovative biotechnology products.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 164,010.640 mill. $ 29,532.000 mill. $ 3,763.000 mill. 536 mill. 43.69 Y/Y 21.98 %
Market Cap. Revenues TTM Net Income TTM

$ 164,010.640 mill.


$ 29,532.000 mill.


$ 3,763.000 mill.

Employees Shares Outstanding P/E

24,200


536 mill.


43.69

Revenue Growth Income Growth

MRQ Y/Y 21.98 %


MRQ Y/Y - %



LLY

$891.46

$24.1600 2.79%
Last 5 Days


LLY

$891.46

$24.1600 2.79%



Eli Lilly And Company

Eli Lilly And Company stock improved 2.79% during the last 5 days.


Eli Lilly and Company operates as a pharmaceutical company, primarily focused on researching, developing, manufacturing, and marketing prescription drugs across various therapeutic areas.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 805,701.548 mill. $ 35,932.100 mill. $ 6,138.400 mill. 904 mill. 131.21 Y/Y 25.98 %
Market Cap. Revenues TTM Net Income TTM

$ 805,701.548 mill.


$ 35,932.100 mill.


$ 6,138.400 mill.

Employees Shares Outstanding P/E

35,000


904 mill.


131.21

Revenue Growth Income Growth

MRQ Y/Y 25.98 %


MRQ Y/Y 66.77 %



HSIC

$68.28

$1.8700 2.82%
Last 5 Days


HSIC

$68.28

$1.8700 2.82%



Henry Schein Inc

Henry Schein Inc stock improved 2.82% during the last 5 days.


Henry Schein Inc is a global distributor of healthcare products, services, and technology solutions to dental and medical professionals. They operate through a vast network of sales consultants, offering a wide range of products from various manufacturers to meet their customers* needs. Their business model focuses on providing high-quality products, innovative solutions, and superior customer service to enhance patient care and improve practice efficiency.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 8,860.667 mill. $ 12,451.000 mill. $ 406.000 mill. 130 mill. 23.00 Y/Y 3.66 %
Market Cap. Revenues TTM Net Income TTM

$ 8,860.667 mill.


$ 12,451.000 mill.


$ 406.000 mill.

Employees Shares Outstanding P/E

21,600


130 mill.


23.00

Revenue Growth Income Growth

MRQ Y/Y 3.66 %


MRQ Y/Y -23.44 %



ABBV

$171.36

$5.2700 3.17%
Last 5 Days


ABBV

$171.36

$5.2700 3.17%



Abbvie Inc

Abbvie Inc shares went up 3.17% during the last 5 days.


Abbvie Inc operates primarily as a global biopharmaceutical company. Its business model centers around researching, developing, manufacturing, and commercializing advanced therapies and medications focusing on critical areas like immunology, oncology, neuroscience, virology, and more. By leveraging its expertise and capabilities, Abbvie aims to improve patient outcomes, address unmet medical needs, and provide value to its stakeholders in the healthcare industry.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 303,821.280 mill. $ 54,403.000 mill. $ 6,004.000 mill. 1,773 mill. 50.78 Y/Y 0.70 %
Market Cap. Revenues TTM Net Income TTM

$ 303,821.280 mill.


$ 54,403.000 mill.


$ 6,004.000 mill.

Employees Shares Outstanding P/E

50,000


1,773 mill.


50.78

Revenue Growth Income Growth

MRQ Y/Y 0.70 %


MRQ Y/Y 469.29 %



LH

$206.5

$10.1400 5.16%
Last 5 Days


LH

$206.5

$10.1400 5.16%



Laboratory Corporation Of America Holdings

Laboratory Corporation Of America Holdings stock improved 5.16% during the last 5 days.


Laboratory Corporation Of America Holdings operates as a leading healthcare diagnostics company. They offer a range of clinical laboratory tests and services to healthcare providers, pharmaceutical companies, and government agencies. Their business model focuses on providing accurate and timely test results, enabling healthcare professionals to diagnose, treat, and monitor patients effectively.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 17,502.602 mill. $ 11,560.300 mill. $ 434.200 mill. 85 mill. 41.71 Y/Y -15.92 %
Market Cap. Revenues TTM Net Income TTM

$ 17,502.602 mill.


$ 11,560.300 mill.


$ 434.200 mill.

Employees Shares Outstanding P/E

75,500


85 mill.


41.71

Revenue Growth Income Growth

MRQ Y/Y -15.92 %


MRQ Y/Y 7.03 %



PDCO

$25.38

$2.5200 11.02%
Last 5 Days


PDCO

$25.38

$2.5200 11.02%



Patterson Companies Inc

Patterson Companies Inc shares went up 11.02% during the last 5 days.


Patterson Companies Inc*s business model focuses on distributing and selling a wide range of products and solutions to various industries, including dental, animal health, and rehabilitation.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2,348.132 mill. $ 6,565.239 mill. $ 193.420 mill. 93 mill. 12.50 Y/Y 0.95 %
Market Cap. Revenues TTM Net Income TTM

$ 2,348.132 mill.


$ 6,565.239 mill.


$ 193.420 mill.

Employees Shares Outstanding P/E

7,000


93 mill.


12.50

Revenue Growth Income Growth

MRQ Y/Y 0.95 %


MRQ Y/Y -11.61 %




 1 Day   Week  Current Month of June  30 Days 
Current Quarter Q2 of 2024  90 Days    Ytd    12 Months 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com